1 Min Read
Oct 10 (Reuters) - Moody‘s:
* Mylan's Epipen settlement is credit negative; ratings unaffected Source text - bit.ly/2dGyVis Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.